Mohammed Eslam

2009–2026 年に発表

122
論文数
24,794
被引用数
56
h 指数
104
i10 指数

被引用数

Mohammed Eslam の年別被引用数1986 年: 被引用 1 件1997 年: 被引用 1 件2000 年: 被引用 1 件2005 年: 被引用 4 件2010 年: 被引用 7 件2011 年: 被引用 11 件2012 年: 被引用 4 件2013 年: 被引用 6 件2014 年: 被引用 11 件2015 年: 被引用 9 件2016 年: 被引用 12 件2017 年: 被引用 28 件2018 年: 被引用 86 件2019 年: 被引用 500 件2020 年: 被引用 1,225 件2021 年: 被引用 2,011 件2022 年: 被引用 1,942 件2023 年: 被引用 1,531 件2024 年: 被引用 2,478 件2025 年: 被引用 1,177 件2026 年: 被引用 61 件1987〜1996 年は被引用が無いため表示していません1998〜1999 年は被引用が無いため表示していません2001〜2004 年は被引用が無いため表示していません2006〜2009 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 2,389 件、この内訳の 19.1%アメリカ合衆国: 引用元論文 1,730 件、この内訳の 13.8%イタリア: 引用元論文 833 件、この内訳の 6.6%イギリス: 引用元論文 690 件、この内訳の 5.5%ドイツ: 引用元論文 478 件、この内訳の 3.8%スペイン: 引用元論文 405 件、この内訳の 3.2%韓国: 引用元論文 383 件、この内訳の 3.1%日本: 引用元論文 373 件、この内訳の 3%オーストラリア: 引用元論文 370 件、この内訳の 3%フランス: 引用元論文 291 件、この内訳の 2.3%インド: 引用元論文 250 件、この内訳の 2%香港: 引用元論文 232 件、この内訳の 1.8%
0%19.1%その他 32.8%

分野

  • Medicine85%
  • Biochemistry, Genetics and Molecular Biology9.3%
  • Immunology and Microbiology1.4%
  • Environmental Science0.8%
  • Neuroscience0.6%
  • Nursing0.6%
  • その他2.3%

トピック

  • Liver Disease Diagnosis and Treatment27%
  • Diet, Metabolism, and Disease6.8%
  • Liver Disease and Transplantation6%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4.2%
  • Alcohol Consumption and Health Effects3.4%
  • Liver Diseases and Immunity2.7%
  • その他49.9%

共著者

全論文

検索で開く
  1. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vlad Ratziu, Jacob George - Journal of Hepatology 2020 被引用: 4,410

  2. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

    著者: , , , , , , , - Nature Reviews Gastroenterology & Hepatology 2017 被引用: 5,259

  3. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vincent Wai‐Sun Wong, Vlad Ratziu, Yusuf Yılmaz, Zobair M. Younossi - Gastroenterology 2020 被引用: 3,274

  4. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , - Hepatology International 2020 被引用: 845

  5. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

    著者: , , , , , , , , , , , , , , , , - Gastroenterology 2018 被引用: 792

  6. Genetics and epigenetics of NAFLD and NASH: Clinical impact

    著者: , , - Journal of Hepatology 2017 被引用: 991

  7. An international multidisciplinary consensus statement on MAFLD and the risk of CVD

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jang Won Son, John Ryan, Ignatios Ikonomidis, Sombat Treeprasertsuk, Daniele Pastori, Monica Lupșor‐Platon, Herbert Tilg, Hasmik Ghazinyan, Jérôme Boursier, Masahide Hamaguchi, Mindie H. Nguyen, Jian‐Gao Fan, George Boon‐Bee Goh, Mamun Al Mahtab, Saeed Hamid, Nilanka Perera, Jacob George, Ming‐Hua Zheng - Hepatology International 2023 被引用: 183

  8. Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals

    著者: , , , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2022 被引用: 308

  9. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hannes Hagström, Camilla Akbari, Masashi Hirooka, Wah‐Kheong Chan, Sanjiv Mahadeva, Ruveena Bhavani Rajaram, Ming‐Hua Zheng, Jacob George, Mohammed Eslam, Salvatore Petta, Grazia Pennisi, Mauro Viganò, Sofia Ridolfo, Guruprasad P. Aithal, Naaventhan Palaniyappan, Dae Ho Lee, Mattias Ekstedt, Patrik Nasr, Christophe Cassinotto, Victor de Lédinghen, Annalisa Berzigotti, Yuly P. Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier‐Poizat, Andreas Geier, Miljen Martić, Theresa Tuthill, Quentin M. Anstee, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides, Quentin M. Anstee, Ann K. Daly, Olivier Govaere, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Beate K. Straub, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas ほか 130 名 - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 187

  10. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission

    著者: , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2019 被引用: 524

  11. Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight

    著者: , , , , , , - Nature Reviews Gastroenterology & Hepatology 2022 被引用: 237

  12. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement

    著者: , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2021 被引用: 272

  13. Global multi-stakeholder endorsement of the MAFLD definition

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manuel Romero‐Gomez, Mohammed Eslam, Maria Lorena Abate, Bahaa Abbas, Ahmed Amr Abbassy, Waleed Abd El Ghany, Amira Abd Elkhalek, Emad Abd ElMajeed, Mohammad Abdalgaber, Mohamed AbdAllah, Marwa Abdallah, Nourhan Abdallah, Shereen Abdelaleem, Yasser Abdelghani, Wael Abdelghany, Safaa Mohamed Abdelhalim, Wafaa Abdelhamid, Nehal Abdelhamid, Nadia A. Abdelkader, Elsayed Abdelkreem, Aly Mohamed Abdelmohsen, Awny Ali Abdelrahman, Sherief M Abd-elsalam, Doaa Abdeltawab, Abdulbaset Abduh, Nada Abdulhakam, Maheeba Abdulla, Navid Abedpoor, Ludovico Abenavoli, Fredrik Åberg, Omala Ablack, Mostafa Abo elftouh, Yousry Esam-Eldin Abo-Amer, Ashraf Aboubkr, Alaa Aboud, Amr M. Abouelnaga, Galal A. Aboufarrag, Ashraf Aboutaleb, Leticia Abundis, Gupse Adalı, Enrique Adames, Leon Adams, Danjuma Adda, Noor Adel, Nada Adel, Muhammad Adel Sayed, Taiba Jibril Afaa, Nawal Afredj, Gulnara Aghayeva, Alessio Aghemo, Carlos A. Aguilar-Salinas, Golo Ahlenstiel, Walid Ahmady, Wafaa Ahmed, Amira Ahmed, Samah Nasser Ahmed, Heba Mostafa Ahmed, Rasha Ahmed, Elmar Aigner, Mesut Akarsu, Maisam Akroush, Umit Akyuz, Mamun Al Mahtab, Tahani Al Qadiri, Yusriya Al Rawahi, Razzaq AL rubaee, Muna Al Saffar, Shahinul Alam, Zaid Al-Ani, Agustín Albillos ほか 957 名 - ˜The œLancet. Gastroenterology & hepatology 2022 被引用: 223

  14. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

    著者: , , , , , , , , , - Liver International 2020 被引用: 409

  15. Breaking new ground: MASLD vs. MAFLD—which holds the key for risk stratification?

    著者: , , , , - Hepatology International 2023 被引用: 84

  16. Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation

    著者: , , , , , , , , , , , , , , , , , - Hepatology 2019 被引用: 322

  17. Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology

    著者: , - Nature Reviews Gastroenterology & Hepatology 2019 被引用: 314

  18. An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ajay Duseja, Adriaan G. Holleboom, Junping Shi, Wah‐Kheong Chan, Yasser Fouad, Junwei Yang, Sombat Treeprasertsuk, Helena Cortez‐Pinto, Masahide Hamaguchi, Manuel Romero‐Gómez, Mamun Al Mahtab, Ponsiano Ocama, Atsushi Nakajima, Chunsun Dai, Mohammed Eslam, Lai Wei, Jacob George, Ming‐Hua Zheng - HepatoBiliary Surgery and Nutrition 2023 被引用: 88

  19. Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study

    著者: , , , , , , , , , , , , , , , - Metabolism 2023 被引用: 80

  20. ADAPT: An Algorithm Incorporating PRO‐C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis

    著者: , , , , , , , , , , , , , , , , , - Hepatology 2018 被引用: 257

  21. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Quentin M. Anstee, Elisabetta Bugianesi - Gut 2021 被引用: 202

  22. Implementation of a liver health check in people with type 2 diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 60

  23. The changing epidemiology of liver diseases in the Asia–Pacific region

    著者: , , , , , , , - Nature Reviews Gastroenterology & Hepatology 2018 被引用: 354

  24. Redefining fatty liver disease: an international patient perspective

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2020 被引用: 186